Preclinical validation of macimorelin, a ghrelin mimetic, as treatment amyotrophic lateral sclerosis (ALS) (2022–2023)
- Grant type:
- MNDRIA Innovator Grants
- Researchers:
-
-
Associate Professor
School of Biomedical SciencesFaculty of Medicine -
Principal Research Fellow
Australian Institute for Bioengineering and Nanotechnology
-
- Funded by:
- Motor Neurone Disease Research Institute of Australia Inc
